Current Medicinal Chemistry


Atta-ur-Rahman, FRS
(32052 citations)
Kings College
University of Cambridge

Nobel Laureates on Editorial Board

Prof. John Gurdon

Prof. Jean-Marie Lehn

Prof. Ferid Murad

Personal Subscription
Become EABM
Become Reviewer
Call for Editor
Volume: 14 Issue: 23, October

The “Parkinsonian Heart”: From Novel Vistas to Advanced Therapeutic Approaches in Parkinsons Disease

Volume:14   Issue: 23
Pp: 2421-2428
Francesco Fornai, Riccardo Ruffoli, Paola Soldani, Stefano Ruggieri and Antonio Paparelli
DOI: 10.2174/092986707782023631
Published on: 01 March, 2012

P2Y Receptors: Focus on Structural, Pharmacological and Functional Aspects in the Brain

Volume:14   Issue: 23
Pp: 2429-2455
W. Fischer and U. Krugel
DOI: 10.2174/092986707782023695
Published on: 01 March, 2012

The Many Roles of Chemokine Receptors in Neurodegenerative Disorders: Emerging New Therapeutical Strategies

Volume:14   Issue: 23
Pp: 2456-2470
Marjelo Mines, Yun Ding and Guo-Huang Fan
DOI: 10.2174/092986707782023686
Published on: 01 March, 2012

The Discovery of the Factor Xa Inhibitor Otamixaban: From Lead Identification to Clinical Development

Volume:14   Issue: 23
Pp: 2471-2481
Kevin R. Guertin and Yong-Mi Choi
DOI: 10.2174/092986707782023659
Published on: 01 March, 2012

Tight Junction Modulators: Promising Candidates for Drug Delivery

Volume:14   Issue: 23
Pp: 2482-2488
M. Kondoh and K. Yagi
DOI: 10.2174/092986707782023640
Published on: 01 March, 2012

Onconeural Versus Paraneoplastic Antigens?

Volume:14   Issue: 23
Pp: 2489-2494
S. B. Eichmuller and A. V. Bazhin
DOI: 10.2174/092986707782023668
Published on: 01 March, 2012

Antiangiogenic Agents: an Update on Small Molecule VEGFR Inhibitors

Volume:14   Issue: 23
Pp: 2495-2516
S. Schenone, F. Bondavalli and M. Botta
DOI: 10.2174/092986707782023622
Published on: 01 March, 2012